 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Research Articles |
Cefuroxime axetil is a orally active prodrug formulation of cefuroxime, which upon absorption undergoes immediate deesterification to free cefuroxime. Cefuroxime axetil offers an in vitro antibacterial spectrum against many gram-positive and some gram-negative organisms. Its beta-lactamase stability makes it useful in treating a variety of infections caused by beta-lactamase-producing strains of Haemophilus influenzae, Branhamella catarrhalis, and Staphylococcus aureus. Cefuroxime axetil has good activity against the Enterobacteriaceae and moderate activity against non-Bacteroides fragilis anaerobes. Clinical studies suggest it is at least as effective as ampicillin, amoxicillin, amoxicillin/clavulanic acid, penicillin V, or cefaclor in the treatment of uncomplicated urinary tract infections, acute otitis media, upper respiratory infections, skin and soft tissue infections, and uncomplicated gonorrhea.
This article has been cited by other articles:
|
|
 |
|
  R. B. Nadelman, S. W. Luger, E. Frank, M. Wisniewski, J. J. Collins, and G. P. Wormser Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease Ann Intern Med, August 15, 1992; 117(4): 273 - 280. [Abstract] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
